Cellular and humoral responses to collagen-polyvinylpyrrolidone administered during short and long periods in humans

Canadian Journal of Physiology and Pharmacology

Volumn 81, Issue 11, 2003, Pages 1029-1035

  Furuzawa Carballeda, Janette ^a,b   Rojas, Emilio ^a   Valverde, Mahara ^a   Castillo, Irma ^a   Diaz De Leon, Lino ^a   Krötzsch, Edgar ^c  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^c Laboratory of Connective Tissue   (Mexico)

Author keywords

Collagen antibodies; Collagen polyvinylpyrrolidone; DNA damage; Hypertrophic scar

Indexed keywords

ANTIBODY; BIOMATERIAL; COLLAGEN; COLLAGEN ANTIBODY; POVIDONE;

ARTICLE; BLOOD CELL; CELL DAMAGE; CONTROLLED STUDY; DNA DAMAGE; DRUG SAFETY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; LIVER METABOLISM; LONG TERM CARE; LYMPHOCYTE PROLIFERATION; METABOLIC DISORDER; NORMAL HUMAN; PRIORITY JOURNAL; SHORT COURSE THERAPY;

ANIMALS; ANTIBODY FORMATION; CELL DIVISION; CELLS, CULTURED; COLLAGEN; COLLAGEN TYPE I; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; DRUG ADMINISTRATION SCHEDULE; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; POVIDONE; SKIN; SKIN TESTS; STATISTICS, NONPARAMETRIC; SWINE;

EID: 0347990353     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y03-101     Document Type: Article

References (39)

1. Barile, L., Furuzawa-Carballeda, J., Krötzsch-Gömez, F.E., Espinosa-Morales, R., Alcalá, M., and Díaz de León, L. 1998. Comparative study of collagen-polyvinylpyrrolidone vs. triamcinolone acetate in systemic sclerosis. Clin. Exp. Rheumatol. 16: 370.
2. Barr, R.J., Stegman, S.J., Orange, M.D., and Irvine, C.A. 1984. Delayed skin test reaction to injectable collagen implant (Zyderm). J. Am. Acad. Dermatol. 10: 652-658.
3. Beard, H.K., Faulk, W.P., Conochie, L.B., and Glynn, L.E. 1977. Some immunological aspects of collagen. Progr. Allergy, 22: 45-106.
4. Bonnet, Ch., Charriere, G., Vaquier, J., Bertin, P., Vergne, P., and Treves, R. 1996. Bovine collagen induced systemic symptoms: antibody formation against bovine and human collagen. J. Rheumatol. 23: 545-547.
5. Charriere, G., Bejot, M., Schnitzler, L., Ville, G., and Hartmann, D.J. 1989. Reactions to a bovine collagen implant. J. Am. Acad. Dermatol. 21: 1203-1208.
6. Chimal-Monroy, J., Bravo-Ruiz, T., Furuzawa-Carballeda, G.J., Lira, J.M., De la Cruz, J.C., Almazán, D.A., Krötzsch-Gómez, F.E., Arrellín, G., and Díaz de Leon, L. 1998. Collagen-PVP accelerates new bone formation of experimentally induced bone defects in rat skull and promotes the expression of osteopontin and SPARC during bone repair of rat femora fractures. Ann. N.Y. Acad. Sci. 857: 232-236.
7. Chimal-Monroy, J., Bravo-Ruiz, T., Krötzsch-Gómez, F.E., and Díaz de León, L. 1997. Implantes de Fibroquel aceleran la formación de hueso nuevo en defectos óseos inducidos experimentalmente en cráneos de rata: un estudio histológico. Rev. Biomed. 8: 81-88.
8. Clark, D.P., Hanke, C.W., and Swanson, N.A. 1989. Dermal implants: safety of products injected for soft tissue agumentation. J. Am. Acad. Dermatol. 21: 992-998.
9. Cummings, J.M., Boullier, J.A., and Parra, R.O. 1996. Transurethral collagen injections in the therpay of post-radical prostatectomy stress incontinence. J. Urol. 155: 1011-1013.
10. DeLustro, P., Fries, J., and Kang, A. 1988. Immunity to injectable collagen and autoimmune disease: a summary of current understanding. J. Dermatol. Surg. Oncol. 14(Suppl. I): 57-65.
11. Elson, M.L. 1988. Clinical assessment of Zyplast implant: a year of experience for soft tissue contour correction. J. Am. Acad. Dermatol. 18: 707-713.
12. Fujimura, K., Bessho, K., Kusumoto, K., Ogawa, Y., and Iizuka., T. 1995. Experimental studies on bone inducing activity of composites of atelopeptide type I collagen as a carrier for ectopic osteoinduction by rhBMP-2. Biochem. Biophys. Res. Commun. 208: 316-322.
13. Furuzawa-Carballeda, J., Rodríguez-Calderón, R., Díaz de León, L., and Alcocer-Varela, J. 2002. Mediators of inflammation are down-regulated while apoptosis is up-regulated in rheumatoid arthritis synovial tissue by polymerized collagen. Clin. Exp. Immunol. 130: 140-149.
14. Gosslau, B., and Barrach, H. 1979. Enzyme-linked immunosorbent microassay for quantification of specific antibodies to collagen type I, II, III. J. Immunol. Methods, 29: 71-77.
15. Hanke, W.C., Higley, H.R., Jolivette, D.M., Swanson, N.A., and Stegman, S.J. 1991. Abscess formation and local necrosis after treatment with Zyderm or Zyplast collagen implant. J. Am. Acad. Dermatol. 25: 319-326.
16. Herrera, J.I., Olmo, N., Turnay, J., Sicilia, A., Bascones, A., Gavilanes, J.G., and Lizarbe, M.A. 1995. Implantation of sepiolite-collagen complexes in surgically created rat calvaria defects. Biomaterials, 16: 625-631.
17. Hoffmann, Ch., Schuller-Petrovic, S., Soyer, P., and Kerl, H. 1999. Adverse reactions after cosmetic lip augmentation with permanent biologically inert implant materials. J. Am. Acad. Dermatol. 40: 100-102.
18. Hyder, P., Singh, G., and Adam, S. 1992. Humoral responses to type I collagen after surgical curettage procedures employing bovine collagen implants. Biomaterials, 13: 693-698.
19. Karam, P., and Kibbi, A.G. 1992. Collagen injections. Int. J. Dermatol. 31: 467-470.
20. Kinoshita, Y., Kuzuhara, T., Kirigakubo, M., Kobayashi, M., Shimura, K., and Ikada, Y. 1993. Reduction in tumor formation on porous polyethylene by collagen immobilization. Biomaterials, 14: 546-550.
21. Krötzsch-Gómez, F.E., Furuzawa-Carballeda, J., Reyes-Márquez, R., Quiróz-Hernández, E., and Díaz de León, L. 1998. Cytokine expression is downregulated by collagen-polyvinylpyrrolidone in hypertrophic scars. J. Invest. Dermatol. 111: 828-834.
22. Leonard, M.P., Canning, D.A., Epstein, J.I., Gearhart, J.P., and Jeffs, R.D. 1990. Local tissue reaction to the suburethral injection of glutaraldehyde cross-linked bovine collagen in humans. J. Urol. 143: 1209-1212.
23. Lewy, R.I. 1994. Autoimmune disease and collagen dermal implants. Ann. Int. Med. 120: 525.
24. McClelland, M., and DeLustro, F. 1996. Evaluation of antibody class in response to bovine collagen treatment in patients with urinary incontinence. J. Urol. 155: 2068-2073.
25. McCoy, J.P., Schade, W., Siegle, R.J., Waldinger, T.P., Vanderveen, E.E., and Swanson, N.A. 1985. Characterization of the humoral immune response to bovine collagen implants. Arch. Dermatol. 121: 990-994.
26. McCoy, J.P., Schade, W., Siegle, R.J., Vanderveen, E.E., Zachary, C.B., Waldinger, T.P., and Swanson, N.A. 1987a. Immune responses to bovine collagen implants. J. Am. Acad. Dermatol. 16: 955-960.
27. McCoy, J.P., Waldinger, T.P., Cohen, K.A., Schade, W., Siegle, R., Hamilton, T.A., and Swanson, N.A. 1987b. Connective tissue diseases and bovine collagen implants. J. Am. Acad. Dermatol. 16: 315-318.
28. Paradis, K., Langford, G., Long, Z., Heneine, W., Sandstrom, P., Switzer, W.M., Chapman, L.E., Lockey, C., Onions, D., and Otto, E. 1999. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group. Science (Washington, D.C.), 285: 1236-1241.
29. Pohunlová, H., and Adam, M. 1995. Reactivity and the fate of some composite bioimplants based on collagen in connective tissue. Biomaterials, 16: 67-71.
30. Polack, S. 1990. Silicone, fibril, and collagen implantation for facial lines and wrinkles. J. Dermatol. Surg. Oncol. 16: 957-961.
31. Robinson, B.V., Sulliven, P.M., Borzelleca, J.F., and Schwartz, P.V.P. 1990. A critical review of the kinetics and toxicology of polyvinylpyrrolidone (Povidone). Lewis Publishers, Inc, Boca Raton, FL. p. 147-149.
32. Rodríguez-Calderón, R., Furuzawa-Carballeda, J., Corchado, A., and Krötzsch, E. 2001. Collagen-polyvinylpyrrolidone promotes human wound healing through cytokine downmodulation. Wound Rep. Reg. 9(2): 166.
33. Rosen, T., and Watkins, H.C. 1990. Use of gelatin matrix implant in patients hypersensitive to bovine collagen. J. Am. Acad. Dermatol. 22: 849-850.
34. Siegle, R.J., McCoy, J.P., Schade, W., and Swanson, N.A. 1984. Intradermal implantation of bovine collagen. Arch. Dermatol. 120: 183-187.
35. Singh, G., and Fries, J.F. 1994. Autoimmune disease and collagen dermal implants. Ann. Int. Med. 120: 524.
36. Soo, C., Rahbar, G., and Moy, R.L. 1993. The immunogenicity of bovine collagen implants. J. Dermatol. Surg. Oncol. 19: 431-434.
37. Tice, R.R., Strauss, G.H.S., and Peters, W.P. 1992. High-dose combination alkylating agents with autologous bone-marrow support in patients with breast cancer: preliminary assessment of DNA damage in individual peripheral blood lymphocytes using the single cell gel electrophoresis assay. Mutation Res. 271: 101-113.
38. Trentham, D.E. 1986. Adverse reactions to bovine collagen implants. Arch. Dermatol. 122: 643-644.
39. Weiss, R.A. 1999. Xenografts and retroviruses. Science (Washington, D.C.), 285: 1221-1222.